Humanigen, Inc.
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19 (NCT04351152) | Humanigen, Inc. | 2020-05-05 |
Track Humanigen, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.